Dennis Sullivan
Concepts (352)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Veterans | 12 | 2023 | 555 | 3.240 |
Why?
| Tai Ji | 3 | 2022 | 22 | 2.220 |
Why?
| Energy Intake | 8 | 2016 | 170 | 1.970 |
Why?
| Apathy | 5 | 2020 | 39 | 1.920 |
Why?
| Nutrition Assessment | 8 | 2016 | 63 | 1.890 |
Why?
| Muscle, Skeletal | 13 | 2018 | 750 | 1.530 |
Why?
| Patient Discharge | 9 | 2023 | 320 | 1.490 |
Why?
| Walking | 5 | 2023 | 94 | 1.480 |
Why?
| Aged | 61 | 2018 | 9310 | 1.470 |
Why?
| Exercise Therapy | 5 | 2017 | 98 | 1.390 |
Why?
| Resistance Training | 5 | 2018 | 92 | 1.350 |
Why?
| Hospitalization | 6 | 2016 | 652 | 1.270 |
Why?
| Aged, 80 and over | 33 | 2018 | 3129 | 1.270 |
Why?
| Mortality | 7 | 2007 | 99 | 1.220 |
Why?
| Activities of Daily Living | 9 | 2017 | 174 | 1.150 |
Why?
| Frail Elderly | 5 | 2007 | 32 | 1.130 |
Why?
| Alzheimer Disease | 6 | 2018 | 324 | 1.080 |
Why?
| Inflammation | 4 | 2012 | 604 | 1.050 |
Why?
| Geriatric Assessment | 10 | 2015 | 112 | 1.040 |
Why?
| Rehabilitation Centers | 5 | 2012 | 34 | 1.000 |
Why?
| Nutritional Status | 9 | 2016 | 141 | 0.940 |
Why?
| Male | 61 | 2020 | 25241 | 0.920 |
Why?
| Muscle Weakness | 4 | 2011 | 44 | 0.920 |
Why?
| Humans | 76 | 2023 | 49974 | 0.900 |
Why?
| Aging | 11 | 2018 | 687 | 0.890 |
Why?
| Dietary Supplements | 2 | 2018 | 443 | 0.850 |
Why?
| Serum Albumin | 4 | 2012 | 58 | 0.810 |
Why?
| Insulin-Like Growth Factor I | 4 | 2018 | 137 | 0.770 |
Why?
| Weight Loss | 5 | 2012 | 237 | 0.750 |
Why?
| Weight Gain | 5 | 2012 | 240 | 0.730 |
Why?
| Postural Balance | 2 | 2020 | 56 | 0.720 |
Why?
| Weight Lifting | 6 | 2007 | 29 | 0.720 |
Why?
| Hip Fractures | 3 | 2009 | 47 | 0.720 |
Why?
| Advance Care Planning | 2 | 2017 | 19 | 0.710 |
Why?
| Head | 1 | 2020 | 73 | 0.700 |
Why?
| Hospitals, Veterans | 7 | 2015 | 110 | 0.690 |
Why?
| Middle Aged | 29 | 2020 | 12069 | 0.690 |
Why?
| Prospective Studies | 15 | 2018 | 2364 | 0.690 |
Why?
| Accidental Falls | 2 | 2020 | 98 | 0.680 |
Why?
| Depressive Disorder | 2 | 2020 | 339 | 0.680 |
Why?
| Protein-Energy Malnutrition | 4 | 2002 | 19 | 0.680 |
Why?
| Female | 45 | 2020 | 26472 | 0.670 |
Why?
| Inpatients | 4 | 2016 | 190 | 0.660 |
Why?
| Thigh | 1 | 2018 | 34 | 0.640 |
Why?
| Teaching | 1 | 2019 | 116 | 0.630 |
Why?
| Muscle Strength | 3 | 2011 | 124 | 0.630 |
Why?
| User-Computer Interface | 1 | 2018 | 81 | 0.620 |
Why?
| Vascular Endothelial Growth Factor D | 1 | 2018 | 6 | 0.620 |
Why?
| Blood Urea Nitrogen | 1 | 2018 | 41 | 0.610 |
Why?
| Advance Directives | 2 | 2017 | 29 | 0.610 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2018 | 106 | 0.600 |
Why?
| Medication Therapy Management | 1 | 2018 | 23 | 0.600 |
Why?
| Nursing Homes | 3 | 2011 | 114 | 0.590 |
Why?
| Megestrol Acetate | 6 | 2007 | 17 | 0.570 |
Why?
| Sensation Disorders | 1 | 2017 | 11 | 0.570 |
Why?
| Transcranial Magnetic Stimulation | 1 | 2018 | 70 | 0.570 |
Why?
| Body Weight | 6 | 2012 | 513 | 0.550 |
Why?
| Enteral Nutrition | 3 | 2004 | 147 | 0.540 |
Why?
| Fear | 1 | 2017 | 82 | 0.530 |
Why?
| Exercise | 10 | 2009 | 495 | 0.530 |
Why?
| Nutrition Disorders | 3 | 2002 | 14 | 0.530 |
Why?
| Physician-Patient Relations | 1 | 2017 | 140 | 0.520 |
Why?
| Kidney Failure, Chronic | 1 | 2018 | 198 | 0.520 |
Why?
| RNA, Messenger | 3 | 2018 | 1105 | 0.500 |
Why?
| Immune System | 1 | 2015 | 44 | 0.500 |
Why?
| Malnutrition | 2 | 2013 | 87 | 0.490 |
Why?
| Videoconferencing | 1 | 2015 | 37 | 0.490 |
Why?
| Adaptation, Physiological | 1 | 2015 | 91 | 0.490 |
Why?
| Clinical Protocols | 1 | 2015 | 108 | 0.480 |
Why?
| C-Reactive Protein | 3 | 2012 | 142 | 0.480 |
Why?
| Tomography, X-Ray Computed | 3 | 2018 | 1159 | 0.460 |
Why?
| Edema | 2 | 2012 | 67 | 0.440 |
Why?
| Neuropsychological Tests | 1 | 2015 | 353 | 0.440 |
Why?
| Hospital Units | 1 | 2012 | 9 | 0.430 |
Why?
| Physical Endurance | 1 | 2012 | 30 | 0.430 |
Why?
| Prealbumin | 2 | 2012 | 21 | 0.430 |
Why?
| Recovery of Function | 2 | 2012 | 188 | 0.420 |
Why?
| Treatment Outcome | 11 | 2018 | 5141 | 0.420 |
Why?
| Leg | 1 | 2012 | 122 | 0.410 |
Why?
| Heart Failure | 1 | 2018 | 458 | 0.410 |
Why?
| Dietary Proteins | 2 | 2012 | 242 | 0.390 |
Why?
| Attitude to Death | 1 | 2011 | 12 | 0.380 |
Why?
| Terminally Ill | 1 | 2011 | 13 | 0.380 |
Why?
| Assisted Living Facilities | 1 | 2011 | 11 | 0.380 |
Why?
| Family Relations | 1 | 2011 | 22 | 0.380 |
Why?
| Testosterone | 5 | 2005 | 139 | 0.380 |
Why?
| Professional-Family Relations | 1 | 2011 | 44 | 0.380 |
Why?
| Antidepressive Agents | 1 | 2012 | 176 | 0.370 |
Why?
| Sound | 1 | 2009 | 11 | 0.340 |
Why?
| Proportional Hazards Models | 5 | 2018 | 402 | 0.340 |
Why?
| Palliative Care | 1 | 2011 | 187 | 0.330 |
Why?
| Pilot Projects | 5 | 2018 | 699 | 0.330 |
Why?
| Muscular Diseases | 1 | 2009 | 58 | 0.320 |
Why?
| Prognosis | 5 | 2018 | 1942 | 0.300 |
Why?
| Geriatrics | 1 | 2008 | 46 | 0.300 |
Why?
| Body Mass Index | 9 | 2009 | 652 | 0.290 |
Why?
| Disabled Persons | 1 | 2008 | 78 | 0.290 |
Why?
| Double-Blind Method | 5 | 2018 | 681 | 0.280 |
Why?
| Food Service, Hospital | 2 | 2016 | 3 | 0.280 |
Why?
| Photography | 2 | 2016 | 32 | 0.280 |
Why?
| Syndrome | 2 | 2020 | 237 | 0.270 |
Why?
| Diet | 3 | 2016 | 566 | 0.260 |
Why?
| Hypoalbuminemia | 1 | 2005 | 4 | 0.260 |
Why?
| Skin Ulcer | 2 | 2015 | 9 | 0.250 |
Why?
| Interleukin-6 | 4 | 2012 | 264 | 0.250 |
Why?
| Body Composition | 7 | 2009 | 318 | 0.240 |
Why?
| Cognition | 3 | 2018 | 338 | 0.240 |
Why?
| Methylphenidate | 2 | 2017 | 75 | 0.240 |
Why?
| Cytokines | 1 | 2007 | 612 | 0.240 |
Why?
| Time Factors | 7 | 2017 | 2903 | 0.240 |
Why?
| Cohort Studies | 4 | 2012 | 1422 | 0.240 |
Why?
| Postoperative Care | 1 | 2004 | 102 | 0.230 |
Why?
| Risk Factors | 6 | 2016 | 3613 | 0.230 |
Why?
| Feasibility Studies | 3 | 2015 | 375 | 0.230 |
Why?
| Obesity | 5 | 2009 | 1113 | 0.230 |
Why?
| Health Status | 3 | 2018 | 298 | 0.230 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2012 | 388 | 0.220 |
Why?
| Appetite | 2 | 2003 | 17 | 0.220 |
Why?
| Diet Records | 2 | 2016 | 17 | 0.210 |
Why?
| Aftercare | 1 | 2023 | 75 | 0.210 |
Why?
| Adipose Tissue | 2 | 2018 | 187 | 0.210 |
Why?
| Central Nervous System Stimulants | 2 | 2017 | 213 | 0.210 |
Why?
| Homes for the Aged | 1 | 2002 | 33 | 0.200 |
Why?
| Cyclobutanes | 1 | 2001 | 3 | 0.190 |
Why?
| Appetite Depressants | 1 | 2001 | 9 | 0.190 |
Why?
| Cross-Over Studies | 2 | 2018 | 224 | 0.190 |
Why?
| Muscle Proteins | 4 | 2009 | 303 | 0.190 |
Why?
| Intubation, Gastrointestinal | 1 | 2000 | 27 | 0.180 |
Why?
| Adult | 11 | 2019 | 13236 | 0.180 |
Why?
| Energy Metabolism | 2 | 2009 | 282 | 0.180 |
Why?
| Magnetics | 1 | 2000 | 39 | 0.180 |
Why?
| Independent Living | 2 | 2017 | 41 | 0.180 |
Why?
| Outpatients | 1 | 2020 | 113 | 0.170 |
Why?
| Quality Improvement | 1 | 2022 | 208 | 0.170 |
Why?
| Algorithms | 1 | 2023 | 615 | 0.170 |
Why?
| Arkansas | 5 | 2008 | 1977 | 0.170 |
Why?
| Hospital Mortality | 2 | 2018 | 409 | 0.160 |
Why?
| Coronary Artery Disease | 1 | 2002 | 274 | 0.160 |
Why?
| Follow-Up Studies | 2 | 2017 | 2182 | 0.160 |
Why?
| Muscles | 2 | 2016 | 103 | 0.160 |
Why?
| Organ Size | 1 | 2018 | 226 | 0.150 |
Why?
| Human Growth Hormone | 1 | 1998 | 50 | 0.150 |
Why?
| United States | 4 | 2015 | 4860 | 0.150 |
Why?
| Executive Function | 1 | 2018 | 76 | 0.140 |
Why?
| Mental Status Schedule | 1 | 2017 | 16 | 0.140 |
Why?
| Age Factors | 4 | 2015 | 1087 | 0.140 |
Why?
| Reproducibility of Results | 2 | 2016 | 1193 | 0.140 |
Why?
| Pandemics | 1 | 2022 | 559 | 0.140 |
Why?
| Wound Healing | 2 | 2015 | 204 | 0.140 |
Why?
| Nutritional Support | 4 | 2013 | 34 | 0.140 |
Why?
| Video Recording | 1 | 2017 | 79 | 0.140 |
Why?
| Cross-Sectional Studies | 2 | 2020 | 1557 | 0.140 |
Why?
| Hyperinsulinism | 2 | 2006 | 26 | 0.130 |
Why?
| Meals | 1 | 2016 | 57 | 0.130 |
Why?
| Caenorhabditis elegans | 1 | 2016 | 138 | 0.130 |
Why?
| Survival Analysis | 3 | 2003 | 653 | 0.130 |
Why?
| Retrospective Studies | 4 | 2020 | 6108 | 0.130 |
Why?
| Negative-Pressure Wound Therapy | 1 | 2015 | 11 | 0.130 |
Why?
| Health Behavior | 1 | 2017 | 254 | 0.120 |
Why?
| Outpatient Clinics, Hospital | 1 | 2015 | 36 | 0.120 |
Why?
| Electric Stimulation Therapy | 1 | 2015 | 23 | 0.120 |
Why?
| Health Status Indicators | 2 | 2008 | 83 | 0.120 |
Why?
| Bone and Bones | 1 | 2018 | 469 | 0.120 |
Why?
| Length of Stay | 2 | 2008 | 619 | 0.120 |
Why?
| Dietary Carbohydrates | 2 | 2006 | 88 | 0.120 |
Why?
| Electronic Health Records | 1 | 2016 | 209 | 0.120 |
Why?
| Decision Making | 1 | 2016 | 265 | 0.120 |
Why?
| Tissue Engineering | 1 | 2015 | 64 | 0.120 |
Why?
| Anti-Infective Agents | 1 | 2015 | 95 | 0.120 |
Why?
| APACHE | 2 | 2004 | 23 | 0.120 |
Why?
| Gene Expression Regulation | 2 | 2009 | 976 | 0.110 |
Why?
| Nutrition Therapy | 1 | 2013 | 21 | 0.110 |
Why?
| Intermediate Care Facilities | 1 | 2012 | 4 | 0.110 |
Why?
| Ubiquitin Thiolesterase | 1 | 2013 | 18 | 0.110 |
Why?
| Ubiquitin | 1 | 2013 | 45 | 0.110 |
Why?
| Regional Blood Flow | 1 | 2012 | 108 | 0.110 |
Why?
| Proteolysis | 1 | 2013 | 94 | 0.100 |
Why?
| Registries | 2 | 2008 | 522 | 0.100 |
Why?
| Citalopram | 1 | 2012 | 17 | 0.100 |
Why?
| Fluoxetine | 1 | 2012 | 42 | 0.100 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2013 | 114 | 0.100 |
Why?
| Patient Care Team | 1 | 2013 | 254 | 0.100 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 138 | 0.090 |
Why?
| Exercise Tolerance | 1 | 2011 | 36 | 0.090 |
Why?
| Narration | 1 | 2011 | 28 | 0.090 |
Why?
| Oxygen Consumption | 4 | 2009 | 183 | 0.090 |
Why?
| Cognition Disorders | 1 | 2012 | 218 | 0.090 |
Why?
| Safety | 2 | 2001 | 78 | 0.090 |
Why?
| T-Lymphocytes | 1 | 2013 | 338 | 0.090 |
Why?
| Myofibrils | 2 | 2007 | 19 | 0.090 |
Why?
| Mass Screening | 1 | 2013 | 353 | 0.090 |
Why?
| Rural Population | 1 | 2015 | 540 | 0.090 |
Why?
| Abdominal Fat | 1 | 2009 | 10 | 0.090 |
Why?
| Sleep | 1 | 2011 | 184 | 0.090 |
Why?
| Polysomnography | 1 | 2009 | 71 | 0.080 |
Why?
| Insurance Claim Review | 1 | 2009 | 36 | 0.080 |
Why?
| Muscle Development | 1 | 2009 | 24 | 0.080 |
Why?
| Communication | 1 | 2011 | 246 | 0.080 |
Why?
| Adiponectin | 1 | 2009 | 64 | 0.080 |
Why?
| Glucose | 2 | 2007 | 344 | 0.080 |
Why?
| Predictive Value of Tests | 2 | 2007 | 903 | 0.070 |
Why?
| Disability Evaluation | 1 | 2008 | 87 | 0.070 |
Why?
| Electroencephalography | 1 | 2009 | 306 | 0.070 |
Why?
| Rest | 1 | 2007 | 63 | 0.070 |
Why?
| Weightlessness | 1 | 2007 | 14 | 0.070 |
Why?
| Medicare | 1 | 2009 | 246 | 0.070 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 104 | 0.070 |
Why?
| Hypertension | 2 | 2002 | 533 | 0.070 |
Why?
| Severity of Illness Index | 2 | 2017 | 945 | 0.070 |
Why?
| Space Flight | 1 | 2007 | 34 | 0.070 |
Why?
| Physical Education and Training | 2 | 2003 | 24 | 0.070 |
Why?
| Glucose Clamp Technique | 1 | 2006 | 15 | 0.070 |
Why?
| Glucose Intolerance | 1 | 2006 | 27 | 0.070 |
Why?
| Proteins | 1 | 2009 | 342 | 0.070 |
Why?
| Glycogen | 1 | 2006 | 41 | 0.070 |
Why?
| Pituitary Hormones, Anterior | 1 | 2005 | 4 | 0.070 |
Why?
| Hormones | 1 | 2005 | 55 | 0.060 |
Why?
| Postoperative Complications | 2 | 2004 | 984 | 0.060 |
Why?
| Pituitary Gland | 1 | 2005 | 86 | 0.060 |
Why?
| Interleukin-15 | 1 | 2004 | 16 | 0.060 |
Why?
| Interleukin-18 | 1 | 2004 | 27 | 0.060 |
Why?
| Regression Analysis | 1 | 2005 | 395 | 0.060 |
Why?
| Diet, Fat-Restricted | 1 | 2004 | 11 | 0.060 |
Why?
| Insulin Resistance | 1 | 2006 | 264 | 0.060 |
Why?
| Marital Status | 1 | 2003 | 19 | 0.060 |
Why?
| Insulin | 1 | 2006 | 457 | 0.060 |
Why?
| Macrophages | 1 | 2006 | 363 | 0.050 |
Why?
| Demography | 1 | 2003 | 93 | 0.050 |
Why?
| Chi-Square Distribution | 1 | 2003 | 280 | 0.050 |
Why?
| Models, Biological | 1 | 2006 | 727 | 0.050 |
Why?
| Lipids | 1 | 2003 | 147 | 0.050 |
Why?
| Anthropometry | 1 | 2002 | 92 | 0.050 |
Why?
| Amino Acids | 1 | 2004 | 360 | 0.050 |
Why?
| Chronic Disease | 2 | 2015 | 567 | 0.050 |
Why?
| Analysis of Variance | 3 | 2012 | 562 | 0.050 |
Why?
| Gonadal Steroid Hormones | 1 | 2002 | 42 | 0.050 |
Why?
| Leptin | 1 | 2003 | 140 | 0.050 |
Why?
| Premenopause | 1 | 2001 | 24 | 0.050 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2009 | 244 | 0.050 |
Why?
| Basal Metabolism | 1 | 2001 | 31 | 0.050 |
Why?
| Drug Therapy, Combination | 2 | 2002 | 377 | 0.050 |
Why?
| Socioeconomic Factors | 1 | 2003 | 581 | 0.050 |
Why?
| Risk | 1 | 2002 | 320 | 0.050 |
Why?
| Radiography, Abdominal | 1 | 2000 | 27 | 0.050 |
Why?
| Gait | 1 | 2001 | 85 | 0.050 |
Why?
| Acute Disease | 1 | 2001 | 366 | 0.040 |
Why?
| Logistic Models | 1 | 2002 | 888 | 0.040 |
Why?
| Blood Pressure | 1 | 2002 | 512 | 0.040 |
Why?
| Heart Rate | 1 | 2001 | 293 | 0.040 |
Why?
| Statistics, Nonparametric | 1 | 1999 | 194 | 0.040 |
Why?
| Ciliary Neurotrophic Factor | 2 | 2009 | 8 | 0.040 |
Why?
| Tissue Inhibitor of Metalloproteinase-1 | 2 | 2009 | 29 | 0.040 |
Why?
| Hypotension, Orthostatic | 1 | 1998 | 5 | 0.040 |
Why?
| Gynecomastia | 1 | 1998 | 4 | 0.040 |
Why?
| Matrix Metalloproteinase 2 | 2 | 2009 | 57 | 0.040 |
Why?
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 1998 | 8 | 0.040 |
Why?
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 1998 | 10 | 0.040 |
Why?
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 1998 | 28 | 0.040 |
Why?
| Cholesterol | 2 | 2012 | 146 | 0.040 |
Why?
| Food, Formulated | 1 | 1997 | 42 | 0.040 |
Why?
| Multivariate Analysis | 1 | 1999 | 577 | 0.040 |
Why?
| Nutritional Requirements | 1 | 1997 | 66 | 0.040 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 595 | 0.040 |
Why?
| Gene Knockdown Techniques | 1 | 2016 | 106 | 0.030 |
Why?
| Recombinant Proteins | 1 | 1998 | 486 | 0.030 |
Why?
| Transferrin | 1 | 1996 | 12 | 0.030 |
Why?
| RNA Interference | 1 | 2016 | 179 | 0.030 |
Why?
| Multiple Myeloma | 1 | 2011 | 2929 | 0.030 |
Why?
| Quality Indicators, Health Care | 1 | 2016 | 86 | 0.030 |
Why?
| Arthroplasty | 1 | 1996 | 28 | 0.030 |
Why?
| Self Report | 1 | 2016 | 196 | 0.030 |
Why?
| Caregivers | 1 | 2017 | 208 | 0.030 |
Why?
| Body Constitution | 2 | 2006 | 12 | 0.030 |
Why?
| Administration, Topical | 1 | 2015 | 56 | 0.030 |
Why?
| Stress, Physiological | 1 | 1996 | 170 | 0.030 |
Why?
| Morbidity | 1 | 1995 | 133 | 0.030 |
Why?
| Canada | 1 | 2015 | 100 | 0.030 |
Why?
| Triglycerides | 2 | 2007 | 159 | 0.030 |
Why?
| Forecasting | 1 | 2015 | 150 | 0.030 |
Why?
| Injections, Intramuscular | 2 | 2003 | 54 | 0.030 |
Why?
| Cysteine Proteinase Inhibitors | 1 | 2013 | 22 | 0.030 |
Why?
| I-kappa B Proteins | 1 | 2013 | 16 | 0.030 |
Why?
| Comorbidity | 1 | 2015 | 615 | 0.030 |
Why?
| Consensus | 1 | 2013 | 148 | 0.030 |
Why?
| Depression | 1 | 2017 | 568 | 0.030 |
Why?
| Acetylcysteine | 1 | 2013 | 100 | 0.030 |
Why?
| Hemostasis | 1 | 2013 | 55 | 0.030 |
Why?
| Drug Administration Schedule | 2 | 2003 | 376 | 0.030 |
Why?
| Disease Progression | 1 | 2015 | 825 | 0.030 |
Why?
| Biomedical Research | 1 | 2015 | 237 | 0.020 |
Why?
| Muscular Atrophy | 1 | 2011 | 70 | 0.020 |
Why?
| Risk Assessment | 1 | 1995 | 1259 | 0.020 |
Why?
| Animals | 2 | 2016 | 13187 | 0.020 |
Why?
| Spectrometry, X-Ray Emission | 1 | 2009 | 7 | 0.020 |
Why?
| Intra-Abdominal Fat | 1 | 2009 | 20 | 0.020 |
Why?
| Blood Glucose | 1 | 2012 | 439 | 0.020 |
Why?
| Quality of Life | 1 | 2015 | 836 | 0.020 |
Why?
| Nitrogen | 1 | 2009 | 66 | 0.020 |
Why?
| Diabetes Mellitus | 1 | 2012 | 285 | 0.020 |
Why?
| Leucine | 1 | 2009 | 116 | 0.020 |
Why?
| Myostatin | 1 | 2007 | 8 | 0.020 |
Why?
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2007 | 16 | 0.020 |
Why?
| Actins | 1 | 2007 | 118 | 0.020 |
Why?
| Young Adult | 1 | 2016 | 3958 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 2007 | 144 | 0.020 |
Why?
| Muscle Contraction | 1 | 2007 | 105 | 0.020 |
Why?
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2006 | 3 | 0.020 |
Why?
| Chemokines, CC | 1 | 2006 | 7 | 0.020 |
Why?
| Receptors, Interleukin-1 | 1 | 2006 | 17 | 0.020 |
Why?
| Macrophage Activation | 1 | 2006 | 25 | 0.020 |
Why?
| Antigens, Differentiation, Myelomonocytic | 1 | 2006 | 39 | 0.020 |
Why?
| Progesterone Congeners | 1 | 2005 | 5 | 0.020 |
Why?
| Body Fat Distribution | 1 | 2005 | 9 | 0.020 |
Why?
| Freezing | 1 | 2005 | 16 | 0.020 |
Why?
| Cell Count | 1 | 2006 | 147 | 0.020 |
Why?
| Interleukin-1 | 1 | 2006 | 104 | 0.020 |
Why?
| Interleukin-10 | 1 | 2006 | 84 | 0.020 |
Why?
| Serum | 1 | 2005 | 32 | 0.020 |
Why?
| Interleukin-1beta | 1 | 2006 | 75 | 0.020 |
Why?
| Receptors, Cell Surface | 1 | 2006 | 122 | 0.020 |
Why?
| Parenteral Nutrition Solutions | 1 | 2004 | 8 | 0.020 |
Why?
| Sarcoplasmic Reticulum | 1 | 2004 | 21 | 0.020 |
Why?
| Solutions | 1 | 2004 | 25 | 0.020 |
Why?
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2004 | 16 | 0.020 |
Why?
| Myosin Heavy Chains | 1 | 2004 | 20 | 0.020 |
Why?
| Electrolytes | 1 | 2004 | 26 | 0.020 |
Why?
| Deuterium | 1 | 2004 | 42 | 0.020 |
Why?
| Antigens, CD | 1 | 2006 | 219 | 0.020 |
Why?
| Protein Isoforms | 1 | 2004 | 119 | 0.010 |
Why?
| Mice | 1 | 2015 | 5739 | 0.010 |
Why?
| Infusions, Intravenous | 1 | 2004 | 206 | 0.010 |
Why?
| Phenylalanine | 1 | 2004 | 128 | 0.010 |
Why?
| Phosphoproteins | 1 | 2004 | 107 | 0.010 |
Why?
| Muscle Fibers, Skeletal | 1 | 2004 | 62 | 0.010 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 197 | 0.010 |
Why?
| Cell Cycle Proteins | 1 | 2004 | 166 | 0.010 |
Why?
| Cholesterol, HDL | 1 | 2003 | 36 | 0.010 |
Why?
| Hormone Replacement Therapy | 1 | 2003 | 27 | 0.010 |
Why?
| Phosphorylation | 1 | 2004 | 535 | 0.010 |
Why?
| Amino Acids, Essential | 1 | 2004 | 131 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2006 | 973 | 0.010 |
Why?
| Carrier Proteins | 1 | 2004 | 304 | 0.010 |
Why?
| Gene Expression Profiling | 1 | 2007 | 1032 | 0.010 |
Why?
| Probability | 1 | 2003 | 164 | 0.010 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2005 | 549 | 0.010 |
Why?
| Protein Biosynthesis | 1 | 2004 | 253 | 0.010 |
Why?
| Biopsy | 1 | 2004 | 584 | 0.010 |
Why?
| Reference Values | 1 | 2003 | 310 | 0.010 |
Why?
| Sensitivity and Specificity | 1 | 2003 | 861 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2003 | 1376 | 0.010 |
Why?
| Postoperative Period | 1 | 1996 | 170 | 0.010 |
Why?
| Adolescent | 1 | 1996 | 6356 | 0.000 |
Why?
|
|
Sullivan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|